---
schema_version: "secwatch.filing_event.v1"
accession: "0001140859-25-000081"
form_type: "8-K"
ticker: "COR"
cik: "0001140859"
company_name: "Cencora, Inc."
filed_at: "2025-05-07T23:59:59+00:00"
generated_at: "2026-05-22T07:03:23.996289+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cencora Q2 FY2025 revenue $75.5B (+10.3% YoY); adj. EPS $4.42 (+16.3%); raises FY guidance

## Summary
- Revenue $75.5B, +10.3% YoY; GAAP diluted EPS $3.68 vs $2.09 prior year.
- Adjusted diluted EPS $4.42, up 16.3% from $3.80; adjusted net income $863M.
- FY2025 adjusted diluted EPS guidance raised to $15.70-$15.95 from $15.30-$15.60.
- CEO Robert Mauch highlights strength of value proposition and pharmaceutical distribution.

## SEC filing metadata
- accession: 0001140859-25-000081
- form_type: 8-K
- ticker: COR
- cik: 0001140859
- company_name: Cencora, Inc.
- filed_at: 2025-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1140859/000114085925000081/0001140859-25-000081-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1140859/000114085925000081/abc-20250507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140859-25-000081
- JSON: https://secwatch.observer/filing/0001140859-25-000081.json
- Plain text: https://secwatch.observer/filing/0001140859-25-000081.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.